On January 8, John Baumgartner from Mizuho Securities reiterated a Hold rating on Herbalife Ltd. (NYSE:HLF) but raised the price target from $11 to $13. Earlier, on January 6, Anthony Vendetti from Maxim Group initiated a Buy rating on the stock with a $20 price target.
Mizuho analysts stated they adjusted price targets for food producers. The firm believes Herbalife Ltd. is expected to grow and outperform in 2026. However, Mizuho cautioned about compressed valuations. The firm cited weak fundamentals and elevated macro uncertainty as reasons valuations remain compressed.
Maxim Group believes a turnaround is underway, which will further solidify the company's position in the health and wellness space. The firm added that regulatory concerns from the United States have been resolved and the company has established a closer connection with distributors, thereby enhancing its supply chain model.
Herbalife Ltd. is a leading nutrition company that offers health and wellness products in approximately 95 markets worldwide. Its offerings include weight management, targeted nutrition, energy, sports, and fitness products.